Rescue experiments showed that treatment with p-STAT3 inhibitor APSTAT3-9R in GC cells overexpressing SLC2A3 significantly restored SLC2A3-mediated promotion of glycolysis reprogramming. This evidence concerns the gene SLC2A3 and gastric cancer.